Cargando…

A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3

Activation of a cellular senescence program is a common response to prolonged oncogene activation or tumor suppressor loss, providing a physiological mechanism for tumor suppression in premalignant cells. The link between senescence and tumor suppression supports the hypothesis that a loss-of-functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahtela, Jenni, Corson, Laura B., Hemmes, Annabrita, Brauer, Matthew J., Koopal, Sonja, Lee, James, Hunsaker, Thomas L., Jackson, Peter K., Verschuren, Emmy W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594263/ https://www.ncbi.nlm.nih.gov/pubmed/23324396 http://dx.doi.org/10.4161/cc.23515

Ejemplares similares

The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis
por: Lahtela, Jenni, et al.
Publicado: (2015)

Spa-RQ: an Image Analysis Tool to Visualise and Quantify Spatial Phenotypes Applied to Non-Small Cell Lung Cancer
por: Bao, Jie, et al.
Publicado: (2019)

Protocol to utilize fresh uncultured human lung tumor cells for personalized functional diagnostics
por: Talwelkar, Sarang S., et al.
Publicado: (2022)

Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras‐driven lung tumours
por: Närhi, Katja, et al.
Publicado: (2018)

Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments
por: Talwelkar, Sarang S., et al.
Publicado: (2021)

Development of an adenosquamous carcinoma histopathology – selective lung metastasis model
por: Lähdeniemi, Iris A. K., et al.
Publicado: (2022)

PI3Kβ inhibition enhances ALK‐inhibitor sensitivity in ALK ‐rearranged lung cancer
por: Talwelkar, Sarang S., et al.
Publicado: (2023)

The ING tumor suppressors in cellular senescence and chromatin
por: Ludwig, Susann, et al.
Publicado: (2011)

EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer
por: Nikas, Ilias, et al.
Publicado: (2022)

EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia
por: Pergaris, Alexandros, et al.
Publicado: (2022)

The putative tumor suppressor gene EphA7 is a novel BMI-1 target
por: Prost, Gaëlle, et al.
Publicado: (2016)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function
por: van Tuyn, John, et al.
Publicado: (2017)

Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2
por: Takasugi, Masaki, et al.
Publicado: (2017)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
por: Blom, Sami, et al.
Publicado: (2017)

A Dimerized HMX1 Inhibits EPHA6/epha4b in Mouse and Zebrafish Retinas
por: Marcelli, Fabienne, et al.
Publicado: (2014)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence
por: Miyajima, Chiharu, et al.
Publicado: (2020)

Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer
por: Pellinen, Teijo, et al.
Publicado: (2022)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor suppressor activities
por: Kagawa, Shingo, et al.
Publicado: (2014)

Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1
por: Panda, Amaresh C., et al.
Publicado: (2017)

Epha2 is a Critical Oncogene in Melanoma
por: Udayakumar, Durga, et al.
Publicado: (2011)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latency
por: Wass, Amanda B., et al.
Publicado: (2022)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma
por: Götze, Silke, et al.
Publicado: (2009)

Prophase I arrest and progression to metaphase I in mouse oocytes are controlled by Emi1-dependent regulation of APC(Cdh1)
por: Marangos, Petros, et al.
Publicado: (2007)

Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathy
por: O'Neal, Wesley T., et al.
Publicado: (2014)

EPHA2 Polymorphisms and Age-Related Cataract in India
por: Sundaresan, Periasamy, et al.
Publicado: (2012)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

EPHA4 is overexpressed but not functionally active in Sézary syndrome
por: Hameetman, Liesbeth, et al.
Publicado: (2015)

Epha3 acts as proangiogenic factor in multiple myeloma
por: Caivano, Antonella, et al.
Publicado: (2017)

Contents list including Graphcal Abstracts
Publicado: (2021)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
por: Barquilla, Antonio, et al.
Publicado: (2016)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_09u6f2i5cig4t8hh2ehs928c69